WED-198 Incidence and clinical significance of recompensation after HCV- cure
Georg Semmler(University of Southern Denmark), Mattias Mandorfer(Medical University of Vienna), Rafael Bañares(Hospital General Universitario Gregorio Marañón), Alberto Zanetto(University of Padua), Sabela Lens(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Francesco Paolo Russo(University of Padua), Elton Dajti(University of Bologna), Zoe Mariñó(Centro de Investigación Biomédica en Red), Sonia Alonso López(Hospital General Universitario Gregorio Marañón), María Luisa Manzano(Hospital Universitario 12 De Octubre), Benjamin Maasoumy(Medizinische Hochschule Hannover), Mònica Pons(Universitat Autònoma de Barcelona), Xavier Forns(Hospital Clínic de Barcelona), Angelo Bruni(Azienda USL di Bologna), Paola Zanaga(University of Padua), Joan Genescà(Universitat Autònoma de Barcelona), Cristina Collazos(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Daniela Neumayer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Mariano Martínez‐Vázquez, Lukas Burghart(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), L. Fritz(Medical University of Vienna), Martin Kabelitz(Medizinische Hochschule Hannover), Lucie Simonis(Medical University of Vienna), Álvaro Hidalgo‐Vega(Weber), D. Ecker(Ordensklinikum Linz Barmherzige Schwestern), Isabel Payeras(Hospital General Universitario Gregorio Marañón)
Cited by 0
Related Papers
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
|Hepatology|1994|599
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239